27
Jul 2026
Leerink partners report names Carterra a core enabler of the $7 B "Lab-in-the-Loop" antibody discovery market
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule discovery, today highlighted new research from Leerink Partners identifying Carterra as a key enabling technology in the fast-growing market for AI-driven biologics drug discovery.